Cold virus weaponized to fight pancreatic cancer in early trial
NCT ID NCT02705196
Summary
This early-stage trial tested the safety of a new treatment called LOAd703 for pancreatic cancer. LOAd703 is a modified common cold virus designed to infect and kill cancer cells while also boosting the body's immune system. The study involved 51 patients who received the virus as injections directly into their tumor, in addition to their standard chemotherapy, to see if it was safe and could help shrink tumors and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor St Luke's Medical Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.